The recent passage of Section 759 didn't just restrict hemp-derived products—it exposed a fundamental problem: superficial compliance practices and an inability to work together toward common regulatory goals. With new federal restrictions, increased civil liability through RICO, and the end of regulatory ambiguity, businesses can no longer afford performative safety measures. During a recent Qredible […]

